Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (111-120 of 204) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|March 1, 1992
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in miceM C Bibby, P M Loadman, A F al-Ghabban, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|March 5, 2022
The priorities of people with mesothelioma and their carers: A qualitative interview study of trial participation and treatment decisionsAnna C Bibby, Anna J Morley, Emma Keenan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumourJ R Masters, B J McDermott, S Harland, et al.
Anticancer Research|April 19, 2000
Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinomaK Grosios, P M Loadman, D J Swaine, et al.
Chest|May 23, 2021
Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected DataNina Holling, Sonia Patole, Andrew R L Medford, et al.
British Journal of Cancer|December 22, 1999
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrugK Grosios, S E Holwell, A T McGown, et al.
British Journal of Cancer|August 1, 1988
The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomideM C Bibby, J A Double, I A Wahed, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomasM I Walton, M C Bibby, J A Double, et al.
Trials|January 10, 2018
Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal productAnna C Bibby, David J Torgerson, Samantha Leach, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1992
Evaluation of the anti-tumour action and acute toxicity of kosins from Hagenia abyssinicaT Z Woldemariam, A F Fell, P A Linley, et al.
Pageof 21

Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|March 1, 1992
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in miceM C Bibby, P M Loadman, A F al-Ghabban, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|March 5, 2022
The priorities of people with mesothelioma and their carers: A qualitative interview study of trial participation and treatment decisionsAnna C Bibby, Anna J Morley, Emma Keenan, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumourJ R Masters, B J McDermott, S Harland, et al.
Anticancer Research|April 19, 2000
Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinomaK Grosios, P M Loadman, D J Swaine, et al.
Chest|May 23, 2021
Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected DataNina Holling, Sonia Patole, Andrew R L Medford, et al.
British Journal of Cancer|December 22, 1999
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrugK Grosios, S E Holwell, A T McGown, et al.
British Journal of Cancer|August 1, 1988
The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomideM C Bibby, J A Double, I A Wahed, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomasM I Walton, M C Bibby, J A Double, et al.
Trials|January 10, 2018
Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal productAnna C Bibby, David J Torgerson, Samantha Leach, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1992
Evaluation of the anti-tumour action and acute toxicity of kosins from Hagenia abyssinicaT Z Woldemariam, A F Fell, P A Linley, et al.
Pageof 21